Ventyx Biosciences

Ventyx Biosciences is advancing a novel pipeline of immune modulatory small molecules to treat immunology and inflammatory (I&I) disorders, namely gastrointestinal and dermatological, along with several other high impact therapeutic areas. The pipeline assets have the potential to drastically impact these high unmet need indications by providing patients with convenient oral therapies that achieve ‘biologic-like’.

Ventyx Biosciences is advancing a novel pipeline of immune modulatory small molecules to treat immunology and inflammatory (I&I) disorders, namely gastrointestinal and dermatological, along with several other high impact therapeutic areas. The pipeline assets have the potential to drastically impact these high unmet need indications by providing patients with convenient oral therapies that achieve ‘biologic-like’ efficacy while maintaining limited toxicity. The Ventyx team brings strong I&I and target expertise, with each asset having potential for best-in-class status.